PharmaVOICE Recognizes Nextrials as a 2015 Innovator

SAN RAMON, CA -- (Marketwired) -- 05/12/15 -- Nextrials, Inc., a leader in clinical research software and services, has been recognized by PharmaVOICE for Prism®'s E2E" electronic health record (EHR) integration tool. The magazine's editors selected E2E for a list of the 16 most innovative platforms serving the health sector for 2015, citing its ability to integrate EHR systems with electronic data capture (EDC) for clinical research. By allowing researchers to extract data directly from EHRs, patient enrollment is easier, transcription errors are eliminated and data queries can be better managed within the platform -- resulting in a quicker, more efficient system for taking novel therapeutics to market.

"Currently, the average length of time to develop a drug ranges from 10 to 15 years," said Nextrials CEO Jim Rogers. "The costs associated with clinical trials are very steep, so delivering relevant patient data to researchers in a cleaner and faster manner saves money and speeds the decision making process. Integration with electronic health records is key to achieving these goals."

Prism has now earned multiple industry awards, including the Society of Clinical Data Management's Innovation Award, and offers pharmaceutical, biotech and medical device researchers an important step forward in achieving complete interoperability of their systems.

To learn more about Nextrials' E2E tool and the complete Prism platform, please click here.

About Nextrials Nextrials offers today's most novel products and services for speeding the delivery of life-saving drugs and medical devices to market. Prism®, its award-winning Electronic Data Capture (EDC) solution, has been used at over 1,500 research sites to streamline the initiation and management of clinical trials. Nextrials has achieved the status of Registered Solutions Provider with the Clinical Data Interchange Standards Consortium (CDISC) for its integration with electronic health records (EHR). The company is headquartered in the San Francisco Bay area. For more information, visit www.nextrials.com or call 925-355-3000.

Contact:
Reid Wegley
VOXUS, Inc.
253-444-5652
[email protected]

Source: Nextrials, Inc.

You May Also Be Interested In

• Venture Global, Inc. Announces Timing of Second Quarter 2026 Earnings Release and Conference Call
• Omni Amelia Island Resort & Spa Completes Resort-Wide Transformation
• Kedrion Biopharma Advances Rare Disease Scientific Evidence Generation at ISTH 2026